Table 1.
Study | Country | Tumor type |
Sample sizes | METTL3 expression High. Low | Survival information | HR | Laboratory method |
---|---|---|---|---|---|---|---|
Yue(2019) | China | GC | 120 | H:40 L:80 | OS | 2.794 | qRT-PCR |
Wang(2019) | China | GC | 166 | H:83 L:83 | OS | 4.495 | qRT-PCR |
Li(2019) | China | CRC | 432 | H: 221 L:211 | OS | 3.259 | qRT-PCR |
Han(2019) | China | BCa | 180 | H:83 L:97 | OS | NA | qRT-PCR |
Jin2019 | China | NSCLC | 50 | H:36 L:14 | OS | 1.3 | qRT-PCR |
Wang(2020) | China | Breast | 60 | H:30 L:30 | OS | 1.6 | qRT-PCR |
Deng(2019) | China | CRC | 181 | H:47 L:134 | OS | 1.908 | qRT-PCR |
Hua(2018) | China | Ovarian | 162 | H:73 L:89 | OS | 1.755 | qRT-PCR |
Liu(2019) | China | CRC | 86 | H:43 L:43 | OS | 2.055 | qRT-PCR |
Abbreviations: GC, gastric cancer; CRC, colorectal carcinoma; BCa, bladder cancer; H, high expreesion of METTL3; L, low expression of METTL3; NA, not associated. qRT-PCR, reverse-transcriptase polymerase chain reaction.